Genmab | GEN - Market Capitalization


Genmab reported DKK134.39B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Almirall EUR 2.76B 472.53M Dec/2025
Amarin USD 290M 51M Dec/2025
Amgen USD 195.44B 5.55B Jun/2026
argenx SE USD 57.63B 13.25B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Bayer EUR 47.56B 8.87B Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Demant DKK 56.79B 10.78B Jun/2026
Exelixis USD 13.54B 2.65B Jun/2026
Fresenius Medical Care EUR 10.55B 766.96M Jun/2026
Genmab DKK 17.1B 88.06B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GN Store Nord DKK 13.17B 2.05B Jun/2026
GRIFOLS EUR 5.41B 181.49M Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Insmed USD 23.11B 12.19B Jun/2026
Lakefront Biotherapeutics EUR 1.73B 2.64M Jun/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 18.98B 27.8B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
UCB EUR 46.41B 13.94B Dec/2025